• Type:

Ancillary processes: a neglected bottleneck in cell therapy manufacturing ?

Play

Jon Ellis, Cell Therapy Manager at Invetech – a global leader in the development and production of automated manufacturing solutions for cell and advanced therapies – comes back on key process, either upstream or downstream, which can constitute bottlenecks when scaling-up cell therapy manufacturing.

Reviews for Ancillary processes: a neglected bottleneck in cell therapy manufacturing ?

There are currently no reviews for Ancillary processes: a neglected bottleneck in cell therapy manufacturing ?
Scroll to top